Assessment of Anti-spike and Neutralizing Antibody Response Against SARS-CoV-2 after Covishield and CovaxinTM Vaccination

Autor: Prachi V. Athavale, Srikanth P. Tripathy, Arjun L. Kakrani, Jitendra S. Bhawalkar, Hanumant Chavan, Poonam Suryawanshi, Bhagyashri R. Patil-Takbhate, Nitin A. Deshpande, Madhura Gandhi, Sujata S. Pawale-Bhingardive, Bhagyashri K. Patil, Priyanka Jali, Dhanashri Kakad

Publikováno v: Medical Journal of Dr. D.Y. Patil Vidyapeeth, Vol 17, Iss 5, Pp 970-977 (2024)

Introduction: This study was conducted to determine total and neutralizing antibody (nAb) titer in individuals at an interval of 2 and 6 months after primary vaccination and after 1 month after administration of booster dose. MATERIALS AND METHODS: A

Externí odkaz: https://doaj.org/article/af62f4ff5bf240199c53a7edceed044e

Knowledge, Attitude, and Practice (KAP) and Perceptions of DFU and Foot Care among Doctors of Various Specialties in Western Maharashtra, India

Autor: Virendra S. Athavale, Prachi V. Athavale

Publikováno v: Medical Journal of Dr. D.Y. Patil Vidyapeeth, Vol 17, Iss 6, Pp 1300-1301 (2024)

Externí odkaz: https://doaj.org/article/154598d160e04a3e9b35e97804ca6392

Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled studyResearch in context

Autor: Prasad S. Kulkarni, Abhijit Kadam, Sheela Godbole, Varsha Bhatt, Abhishek Raut, Sunil Kohli, Santanu Tripathi, Praveen Kulkarni, Rakhi Ludam, Madhav Prabhu, Ashish Bavdekar, Nithya J. Gogtay, Sushant Meshram, Tamilarasu Kadhiravan, Sonali Kar, D.H. Ashwath Narayana, Clarence Samuel, Govind Kulkarni, Abhay Gaidhane, Dipu Sathyapalan, Sidram Raut, Vijay Hadda, Hira Lal Bhalla, Chetanraj Bhamare, Abhijeet Dharmadhikari, Joyce S. Plested, Shane Cloney-Clarke, Mingzhu Zhu, Melinda Pryor, Stephanie Hamilton, Madhuri Thakar, Ashwini Shete, Manish Gautam, Nivedita Gupta, Samiran Panda, Umesh Shaligram, Cyrus S. Poonawalla, Balram Bhargava, Bhagwat Gunale, Dhananjay Kapse, Shubhangi A. Kanitkar, Arjun L. Kakrani, Srikanth P. Tripathy, Abhijit V. Tilak, Akshay A. Dhamne, Shahzad Beg Mirza, Prachi V. Athavale, Mandakini Bhowmik, Parag J. Ratnakar, Subodh Gupta, Vijayshri Deotale, Jyoti Jain, Ashwini Kalantri, Vineet Jain, Nidhi Goyal, Alok Arya, Temsunaro Rongsen-Chandola, Shreyasi Dasgupta, Pratibha Periera, Vanmathi A, Anand Kawade, Arunkumar Gondhali, Palvi Kudyar, Abhishek Singh, Ravi Yadav, Alina Alexander, Venugopalan Gunasekaran, Sekar Dineshbabu, P.C. Samantaray, H.S. Ravish, Deepshikha Kamra, Shilpa Gaidhane, Quazi Syed Zahiruddin, Merlin Moni, Anil Kumar, Ameet Dravid, Anant Mohan, Tejas Suri, Tejas K. Patel, Surekha Kishore, Rahul Choche, Deepak Ghatage, Sugam Salvi

Publikováno v: The Lancet Regional Health - Southeast Asia, Vol 10, Iss , Pp 100139- (2023)

Summary: Background: NVX-CoV2373, a Covid-19 vaccine was developed in the USA with ∼90% efficacy. The same vaccine is manufactured in India after technology transfer (called as SII-NVX-CoV2373), was evaluated in this phase 2/3 immuno-bridging study

Externí odkaz: https://doaj.org/article/82d9dafd89e042aabbf3940c237b71b1

Prevalence of anal human papillomavirus infection among HIV-infected women from India

Autor: Sheela Godbole, Prachi V. Athavale, Ramesh S. Paranjape, Shweta Chidrawar, Manisha M. Ratnaparkhi, Jyoti Pawar, Arati Mane, Usha Katti, Arun Risbud, Mallika Alexander, Shubhangi Kalgutkar

Publikováno v: Journal of acquired immune deficiency syndromes (1999). 67(3)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f92611cc613a5415e71b4d210ef2a0f
https://pubmed.ncbi.nlm.nih.gov/25171734